BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability

Cell Reports

Volumn 7, Issue 5, 2014, Pages 1547-1559

  Yata, Keiko ^a,e   Bleuyard, Jean Yves ^a   Nakato, Ryuichiro ^b,c   Ralf, Christine ^a   Katou, Yuki ^b   Schwab, RebekkaA ^d   Niedzwiedz, Wojciech ^d   Shirahige, Katsuhiko ^b,c   Esashi, Fumiko ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE; DNA; POLO LIKE KINASE 1; RAD51 PROTEIN; BRCA2 PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; EXONUCLEASE; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; RAD1 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BREAST CANCER; CELL CYCLE; CONTROLLED STUDY; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; AMINO TERMINAL SEQUENCE; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

BRCA2 PROTEIN; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 2; DNA REPLICATION; EXONUCLEASES; GENOMIC INSTABILITY; HEK293 CELLS; HELA CELLS; HUMANS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 84902315945     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.04.023     Document Type: Article

References (50)

1. Ayoub N., Rajendra E., Su X., Jeyasekharan A.D., Mahen R., Venkitaraman A.R. The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry. Curr. Biol. 2009, 19:1075-1085.
2. Barr F.A., Silljé H.H., Nigg E.A. Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol. 2004, 5:429-440.
3. Bleuyard J.Y., Buisson R., Masson J.Y., Esashi F. ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair. EMBO Rep. 2012, 13:135-141.
4. Bruhn C., Zhou Z.W., Ai H., Wang Z.Q. The essential function of the MRN complex in the resolution of endogenous replication intermediates. Cell Rep 2014, 6:182-195.
5. Bruinsma W., Raaijmakers J.A., Medema R.H. Switching Polo-like kinase-1 on and off in time and space. Trends Biochem. Sci. 2012, 37:534-542.
6. Dalton W.B., Nandan M.O., Moore R.T., Yang V.W. Human cancer cells commonly acquire DNA damage during mitotic arrest. Cancer Res. 2007, 67:11487-11492.
7. Davies T.G., Bentley J., Arris C.E., Boyle F.T., Curtin N.J., Endicott J.A., Gibson A.E., Golding B.T., Griffin R.J., Hardcastle I.R., et al. Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor. Nat. Struct. Biol. 2002, 9:745-749.
8. Deardorff M.A., Bando M., Nakato R., Watrin E., Itoh T., Minamino M., Saitoh K., Komata M., Katou Y., Clark D., et al. HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature 2012, 489:313-317.
9. Ehrhardt C., Schmolke M., Matzke A., Knoblauch A., Will C., Wixler V., Ludwig S. Polyethylenimine, a cost-effective transfection reagent. Signal Transduct. 2006, 6:179-184.
10. Elia A.E., Rellos P., Haire L.F., Chao J.W., Ivins F.J., Hoepker K., Mohammad D., Cantley L.C., Smerdon S.J., Yaffe M.B. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 2003, 115:83-95.
11. Esashi F., Christ N., Gannon J., Liu Y., Hunt T., Jasin M., West S.C. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 2005, 434:598-604.
12. Giunta S., Belotserkovskaya R., Jackson S.P. DNA damage signaling in response to double-strand breaks during mitosis. J.Cell Biol. 2010, 190:197-207.
13. Goggins M., Schutte M., Lu J., Moskaluk C.A., Weinstein C.L., Petersen G.M., Yeo C.J., Jackson C.E., Lynch H.T., Hruban R.H., Kern S.E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 1996, 56:5360-5364.
14. Hans F., Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001, 20:3021-3027.
15. Hashimoto Y., Ray Chaudhuri A., Lopes M., Costanzo V. Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat. Struct. Mol. Biol. 2010, 17:1305-1311.
16. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002, 297:606-609.
17. Hucl T., Rago C., Gallmeier E., Brody J.R., Gorospe M., Kern S.E. A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 2008, 68:5023-5030.
18. Iacovoni J.S., Caron P., Lassadi I., Nicolas E., Massip L., Trouche D., Legube G. High-resolution profiling of gammaH2AX around DNA double strand breaks in the mammalian genome. EMBO J. 2010, 29:1446-1457.
19. Jackson D.A., Pombo A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J.Cell Biol. 1998, 140:1285-1295.
20. Kliszczak A.E., Rainey M.D., Harhen B., Boisvert F.M., Santocanale C. DNA mediated chromatin pull-down for the study of chromatin replication. Sci Rep 2011, 1:95.
21. Lancaster J.M., Wooster R., Mangion J., Phelan C.M., Cochran C., Gumbs C., Seal S., Barfoot R., Collins N., Bignell G., et al. BRCA2 mutations in primary breast and ovarian cancers. Nat. Genet. 1996, 13:238-240.
22. Lee M., Daniels M.J., Venkitaraman A.R. Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression. Oncogene 2004, 23:865-872.
23. Lin H.R., Ting N.S., Qin J., Lee W.H. M phase-specific phosphorylation of BRCA2 by Polo-like kinase 1 correlates with the dissociation of the BRCA2-P/CAF complex. J.Biol. Chem. 2003, 278:35979-35987.
24. Lo T., Pellegrini L., Venkitaraman A.R., Blundell T.L. Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair and cancer. DNA Repair (Amst.) 2003, 2:1015-1028.
25. Lomonosov M., Anand S., Sangrithi M., Davies R., Venkitaraman A.R. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev. 2003, 17:3017-3022.
26. Lowery D.M., Clauser K.R., Hjerrild M., Lim D., Alexander J., Kishi K., Ong S.E., Gammeltoft S., Carr S.A., Yaffe M.B. Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate. EMBO J. 2007, 26:2262-2273.
27. Moldovan G.L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
28. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 2004, 116:221-234.
29. Ochiai K., Yoshikawa Y., Yoshimatsu K., Oonuma T., Tomioka Y., Takeda E., Arikawa J., Mominoki K., Omi T., Hashizume K., Morimatsu M. Valine 1532 of human BRC repeat 4 plays an important role in the interaction between BRCA2 and RAD51. FEBS Lett. 2011, 585:1771-1777.
30. Pellegrini L., Venkitaraman A. Emerging functions of BRCA2 in DNA recombination. Trends Biochem. Sci. 2004, 29:310-316.
31. Pellegrini L., Yu D.S., Lo T., Anand S., Lee M., Blundell T.L., Venkitaraman A.R. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 2002, 420:287-293.
32. Petermann E., Orta M.L., Issaeva N., Schultz N., Helleday T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 2010, 37:492-502.
33. Quignon F., Rozier L., Lachages A.M., Bieth A., Simili M., Debatisse M. Sustained mitotic block elicits DNA breaks: one-step alteration of ploidy and chromosome integrity in mammalian cells. Oncogene 2007, 26:165-172.
34. Rajendra E., Venkitaraman A.R. Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase. Nucleic Acids Res. 2010, 38:82-96.
35. Schlacher K., Christ N., Siaud N., Egashira A., Wu H., Jasin M. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 2011, 145:529-542.
36. Schlacher K., Wu H., Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 2012, 22:106-116.
37. Schwab R.A., Blackford A.N., Niedzwiedz W. ATR activation and replication fork restart are defective in FANCM-deficient cells. EMBO J. 2010, 29:806-818.
38. Sirbu B.M., Couch F.B., Feigerle J.T., Bhaskara S., Hiebert S.W., Cortez D. Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev. 2011, 25:1320-1327.
39. Sirbu B.M., Couch F.B., Cortez D. Monitoring the spatiotemporal dynamics of proteins at replication forks and in assembled chromatin using isolation of proteins on nascent DNA. Nat. Protoc. 2012, 7:594-605.
40. Song B., Liu X.S., Davis K., Liu X. Plk1 phosphorylation of Orc2 promotes DNA replication under conditions of stress. Mol. Cell. Biol. 2011, 31:4844-4856.
41. Su X., Bernal J.A., Venkitaraman A.R. Cell-cycle coordination between DNA replication and recombination revealed by a vertebrate N-end rule degron-Rad51. Nat. Struct. Mol. Biol. 2008, 15:1049-1058.
42. Svendsen J.M., Smogorzewska A., Sowa M.E., O'Connell B.C., Gygi S.P., Elledge S.J., Harper J.W. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 2009, 138:63-77.
43. Thorslund T., McIlwraith M.J., Compton S.A., Lekomtsev S., Petronczki M., Griffith J.D., West S.C. The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA. Nat. Struct. Mol. Biol. 2010, 17:1263-1265.
44. Trenz K., Errico A., Costanzo V. Plx1 is required for chromosomal DNA replication under stressful conditions. EMBO J. 2008, 27:876-885.
45. Tsvetkov L., Stern D.F. Interaction of chromatin-associated Plk1 and Mcm7. J.Biol. Chem. 2005, 280:11943-11947.
46. van Vugt M.A.T.M., Gardino A.K., Linding R., Ostheimer G.J., Reinhardt H.C., Ong S.E., Tan C.S., Miao H., Keezer S.M., Li J.J., et al. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint. PLoS Biol. 2010, 8:e1000287.
47. Vassilev L.T., Tovar C., Chen S., Knezevic D., Zhao X., Sun H., Heimbrook D.C., Chen L. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl. Acad. Sci. USA 2006, 103:10660-10665.
48. West S.C. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 2003, 4:435-445.
49. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-792.
50. Yata K., Lloyd J., Maslen S., Bleuyard J.Y., Skehel M., Smerdon S.J., Esashi F. Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair. Mol. Cell 2012, 45:371-383.